SG Americas Securities LLC Buys 16,130 Shares of Humana Inc. (NYSE:HUM)

SG Americas Securities LLC boosted its position in Humana Inc. (NYSE:HUM - Free Report) by 570.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,958 shares of the insurance provider's stock after buying an additional 16,130 shares during the period. SG Americas Securities LLC's holdings in Humana were worth $5,016,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. FPC Investment Advisory Inc. acquired a new position in Humana in the fourth quarter valued at $27,000. Centricity Wealth Management LLC acquired a new position in Humana in the fourth quarter valued at $30,000. LFA Lugano Financial Advisors SA increased its stake in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new stake in Humana in the fourth quarter valued at $33,000. Finally, Riverview Trust Co bought a new stake in Humana in the first quarter valued at $34,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Barclays decreased their price target on shares of Humana from $273.00 to $268.00 and set an "equal weight" rating for the company in a research note on Thursday. Robert W. Baird lifted their price target on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Wall Street Zen downgraded shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday. Oppenheimer lifted their price target on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Finally, JPMorgan Chase & Co. decreased their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Seventeen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $284.24.

Humana Stock Down 0.0%

NYSE:HUM traded down $0.09 on Friday, hitting $234.87. The stock had a trading volume of 1,512,489 shares, compared to its average volume of 1,794,248. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market cap of $28.35 billion, a P/E ratio of 23.60, a price-to-earnings-growth ratio of 2.05 and a beta of 0.43. Humana Inc. has a 1 year low of $212.45 and a 1 year high of $406.46. The firm's fifty day simple moving average is $250.43 and its two-hundred day simple moving average is $262.65.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The company's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the business posted $7.23 EPS. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.